Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study

詳細情報 詳細情報について

• CRID

  1363670319769622784

• DOI

  10.1186/1465-9921-15-78

• ISSN

  1465993X

• Web Site

  http://link.springer.com/content/pdf/10.1186/1465-9921-15-78.pdf

• データソース種別

  • Crossref